Log In Sign Up Premium
#1 AI Stock to Buy
  • Markets
    • News
    • Tech
    • Market Movers
    • Futures Forex
    • Macroeconomic Predictions
    • Economy
    • Industries
    • Options
  • Insider Trading
    • Main
    • Education Center
    • Insider Trading Screener
    • Insider Purchases
    • Insider Sales
    • Browse Companies
    • Transcripts
    • Latest 13D & 13G Filings
  • Hedge Funds
    • Main
    • Billionaire Index
    • Education Center
    • Browse Hedge Funds
    • Investor Letters
    • Best Performing
    • Worst Performing
    • Other Institutional Investors
  • Retirement
    • ETF Trading
    • Commodities
    • Gold
    • Dividend Stocks
  • Opinion
    • Main
    • Hedge Fund Analysis
    • Stock Analysis
    • We Disagree
    • Lists
    • Authors
  • Premium
    • Newsletters
    • My Subscriptions
    • Premium Readership
  • Log In
  • Sign Up

Our #1 AI Stock Pick — 33% OFF: $9.99 (was $14.99)  Monthly picks · Ad-free browsing · 30-day money back guarantee

Our #1 AI Stock Pick — 33% OFF: $9.99 (was $14.99)  Monthly picks · Ad-free browsing

Unlock Now — $9.99
Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for Sorry, no results has been found matching your query.
Venkatesh Srinivasalu

Author Profile

Venkatesh Srinivasalu

Contributor

Venkatesh is a financial markets expert with an MBA in Finance and over a decade of experience as a financial analyst. He has worked with leading brokerages and research firms, specializing in stock market analysis, cryptocurrency trends, and hedge fund strategies. At Insider Monkey, Venkatesh shares his expertise to help readers positive and navigate complex financial landscapes and make informed investment decisions.

Contributing since: 2025

Contact the editorial team Disclosure policy

Articles by Venkatesh Srinivasalu

Alnylam (ALNY): Can the RNAi Franchise Get it an Entry into the S&P 500 Index?

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is a biotechnology company built on RNA interference, a technique that switches off the genes behind certain diseases.

Keep Reading →

October 20 - Hedge Funds, News

Okta (OKTA): Does the AI-Identity Turnaround Make It a Stronger S&P 500 Contestant?

Okta, Inc. (NASDAQ:OKTA) sells identity software, the tools that let employees and customers log in securely across a company's many apps.

Keep Reading →

October 20 - Hedge Funds, News

Affirm Holdings (AFRM): Has BNPL’s Profitability Turn Earned It an Index Seat?

Affirm Holdings, Inc. (NASDAQ:AFRM) is the largest of the "buy now, pay later" lenders. The company lets shoppers split purchases into installments at online checkouts.

Keep Reading →

October 20 - Hedge Funds, News

First Citizens (FCNCA): Is the SVB-Boosted Bank Still Undervalued for the S&P 500 Index?

First Citizens BancShares, Inc. (NASDAQ:FCNCA) is a large regional bank whose earnings were transformed when it acquired the failed Silicon Valley Bank.

Keep Reading →

October 20 - Hedge Funds, News

Samsara (IOT): Does a Fourth Straight Profitable Quarter Ensures its Entry into the Index?

Samsara Inc. (NYSE:IOT) sells software and sensors that help businesses track their vehicles, equipment, and workers in real time.

Keep Reading →

October 20 - Hedge Funds, News

Ciena (CIEN): Is the AI-Optical Boom Enough to Carry It Into the S&P 500?

Ciena Corporation (NYSE:CIEN) makes the optical networking gear that carries data across the internet's backbone and between data centers, the physical plumbing behind the AI ...

Keep Reading →

October 20 - Hedge Funds, News

United Therapeutics (UTHR): Can the Profit-Machine Biotech Finally Crack the S&P 500?

United Therapeutics Corporation (NASDAQ:UTHR) develops treatments for pulmonary arterial hypertension, a rare and dangerous high blood pressure in the lungs, with its Tyvaso franchise...

Keep Reading →

October 20 - Hedge Funds, News

Astera Labs (ALAB): Is the AI-Connectivity Competitor Ready for the S&P 500?

Astera Labs, Inc. (NASDAQ:ALAB) makes the specialized chips and hardware that move data between processors, memory, and accelerators inside AI data centers.

Keep Reading →

October 20 - Hedge Funds, News

Zoom (ZM): Is Cash-Rich Compounder Being Overlooked as a Potential Entrant?

Zoom Communications, Inc. (NASDAQ:ZM) is the video-meetings company that became a household name during the pandemic and is now remaking itself into an AI-first work platform.

Keep Reading →

October 20 - Hedge Funds, News

9 New Contenders for S&P 500 Index

Joining the S&P 500 is one of the clearest signs that a company has arrived.

Keep Reading →

October 20 - Hedge Funds, News

Waste Management (WM) vs. Republic Services (RSG): Which Trash Giant Is the Better Buy?

Waste Management, Inc. (NYSE:WM) and Republic Services, Inc.

Keep Reading →

October 12 - Hedge Funds, News

Sherwin-Williams (SHW) vs. PPG Industries (PPG): Which Paint Giant Is the Better Buy?

The Sherwin-Williams Company (NYSE:SHW) and PPG Industries, Inc.

Keep Reading →

October 11 - Hedge Funds, News

Chubb (CB) vs. Travelers (TRV): Which P&C Insurance Giant Is the Better Buy?

Chubb Limited (NYSE:CB) and The Travelers Companies, Inc. (NYSE:TRV) are two of the best property-and-casualty insurers in the world.

Keep Reading →

October 11 - Hedge Funds, News

Could an FDA Nod for MR-141 Give Viatris (VTRS) and Opus Genetics (IRD) a Presbyopia Payoff?

Viatris Inc. (NASDAQ:VTRS) and Opus Genetics, Inc. (NASDAQ:IRD) are waiting on the same decision.

Keep Reading →

October 9 - Hedge Funds, News

Verisk Analytics (VRSK): Is Its Insurance-Data Moat Wide Enough to Justify the Price?

Verisk Analytics, Inc. (NASDAQ:VRSK) is a highly valued data company among the property-and-casualty insurers.

Keep Reading →

October 8 - Hedge Funds, News

Equifax (EFX) vs. TransUnion (TRU): Which Beaten-Down Credit Bureau Is the Better Buy?

Equifax Inc. (NYSE:EFX) and TransUnion (NYSE:TRU) are two of the three big credit bureaus, oligopoly toll booths that get paid whenever a lender checks someone's credit.

Keep Reading →

October 8 - Hedge Funds, News

Public Storage (PSA) vs. Extra Space (EXR): Which Self-Storage REIT Is the Better Buy?

Public Storage (NYSE:PSA) and Extra Space Storage Inc. (NYSE:EXR) are the two giants of self-storage, a recession-resilient corner of real estate.

Keep Reading →

October 8 - Hedge Funds, News

CoStar (CSGP): Is the Homes.com Gamble Destroying a Great Business, or Hiding One?

CoStar Group, Inc. (NASDAQ:CSGP) owns the data that the commercial-real-estate industry runs on, a near-monopoly built over decades.

Keep Reading →

October 7 - Hedge Funds, News

Ecolab (ECL): Is Its Water-and-Hygiene Moat as Sticky as It Looks?

Ecolab Inc. (NYSE:ECL) sells water treatment, cleaning, and pest-control programs that keep restaurants, hotels, hospitals, and factories running safely.

Keep Reading →

October 7 - Hedge Funds, News

Automatic Data Processing (ADP): Is Its Payroll Moat and Float Windfall Built to Last?

Automatic Data Processing, Inc. (NASDAQ:ADP) runs payroll and human-resources software for hundreds of thousands of businesses.

Keep Reading →

October 7 - Hedge Funds, News

Moody’s vs. S&P Global: Which Ratings-Duopoly Stock Is the Better Buy?

Moody's Corporation (NYSE:MCO) and S&P Global Inc. (NYSE:SPGI) are the two halves of one of the best moats in finance.

Keep Reading →

October 7 - Hedge Funds, News

CME Group (CME) vs. Intercontinental Exchange (ICE): Which Exchange Giant Is the Better Buy?

CME Group Inc. (NASDAQ:CME) and Intercontinental Exchange, Inc.

Keep Reading →

October 7 - Hedge Funds, News

Waste Management (WM): Is Its Landfill Moat the Best in the Market?

Waste Management, Inc. (NYSE:WM) operates the largest network of permitted solid waste landfills in North America.

Keep Reading →

October 5 - Hedge Funds, News

Sherwin-Williams (SHW): Is Its Pro-Painter Distribution Moat Underappreciated?

The Sherwin-Williams Company (NYSE:SHW) is usually called a paint company, but its real advantage is where it sells.

Keep Reading →

October 5 - Hedge Funds, News

MSCI (MSCI): Is Its Index Toll Booth on Passive Investing Unbreakable?

MSCI Inc. (NYSE:MSCI) owns some of the most-used stock-market benchmarks in the world, like MSCI Emerging Markets and EAFE.

Keep Reading →

October 5 - Hedge Funds, News

Ferrari (RACE): Is Its Scarcity-Driven Luxury Moat Unbreakable?

Ferrari N.V. (NYSE:RACE) is technically a carmaker, but the market does not price it like one.

Keep Reading →

October 3 - Hedge Funds, News

Philip Morris (PM): Is Its Smoke-Free Transformation a Durable Growth Engine?

Philip Morris International Inc. (NYSE:PM) has turned a shrinking cigarette business into a growth story.

Keep Reading →

October 3 - Hedge Funds, News

Moody’s (MCO): Is Its Credit-Ratings Duopoly Moat Unbreakable?

Moody's Corporation (NYSE:MCO) sits behind one of the strongest moats in finance. Alongside S&P Global, it forms a near-duopoly that rates most of the world's debt.

Keep Reading →

October 3 - Hedge Funds, News

Chipotle (CMG): Is the Growth Runway Still Long Enough to Justify the Premium?

Chipotle Mexican Grill, Inc. (NYSE:CMG) was a hyper-growth stock that always carried a premium price.

Keep Reading →

October 2 - Hedge Funds, News

Intuitive Surgical (ISRG): Is Its Robotic-Surgery Moat Still Untouchable?

Intuitive Surgical, Inc. (NASDAQ:ISRG) more or less invented modern robotic surgery with its da Vinci system, and for two decades it had the field to itself.

Keep Reading →

October 2 - Hedge Funds, News

Acuity (AYI) Brands Downgraded on a Softening Lighting Market: Cyclical Dip or Structural Slowdown?

Acuity Inc. (NYSE:AYI) is the largest lighting company in the U.S., best known for the fixtures that light offices, stores, and warehouses.

Keep Reading →

September 30 - Hedge Funds, News

Pegasystems (PEGA) Is Down 51% and Just Got Downgraded on AI Fears. Victim or Bargain?

Pegasystems Inc.

Keep Reading →

September 30 - Hedge Funds, News

Can AI Really Disrupt Pest Control? Wall Street Thinks So, and Rollins (ROL) Just Hit New Lows

Rollins, Inc. (NYSE:ROL) is among the biggest pest-control companies in the U.S. On September 24, 2026, the stock fell 6.4% to $30.40.

Keep Reading →

September 25 - Hedge Funds, News

First Solar (FSLR) Keeps Hitting New Lows While Wall Street Says Buy. Who’s Right?

First Solar, Inc. (NASDAQ:FSLR) is among the largest US-based solar panel makers. The company is known for a homegrown technology meant to differ from Chinese peers.

Keep Reading →

September 25 - Hedge Funds, News

Gold Is High, So Why Did Kinross (KGC) Just Fall 12%?

Kinross Gold Corporation (NYSE:KGC) is one of the world's larger gold miners. The company has mines across the Americas and West Africa.

Keep Reading →

September 25 - Hedge Funds, News

Gildan (GIL) Has Halved Since Buying HanesBrands. Bargain or Broken Deal?

Gildan Activewear Inc. (NYSE:GIL) is the largest manufacturer of basic blank activewear.

Keep Reading →

September 25 - Hedge Funds, News

Gen Digital (GEN) Wants to Buy GoDaddy. So Why Did Its Own Stock Crash 12%?

Gen Digital Inc. (NASDAQ:GEN) offers consumer cyber-safety software that protects home computers and personal identities.

Keep Reading →

September 25 - Hedge Funds, News

A Cruise Line Betting on Land: Is Royal Caribbean’s Sandals Deal Genius or Overreach?

Royal Caribbean Cruises Ltd. (NYSE:RCL) is the world's second-largest cruise company.

Keep Reading →

September 24 - Hedge Funds, News

Allstate Trades at 5x Earnings. Deep Value, or a Warning That Profits Have Peaked?

The Allstate Corporation (NYSE:ALL) is one of the largest personal property and casualty insurers in the U.S.

Keep Reading →

September 24 - Hedge Funds, News

LPL Financial (LPLA) Drops 7.5%. Is the Stock a Bargain After the Drop?

LPL Financial Holdings Inc. (NASDAQ:LPLA) is the largest independent broker-dealer in the U.S.

Keep Reading →

September 24 - Hedge Funds, News

GE HealthCare (GEHC) is Down 28% and Wall Street is Starting to Buy. Is the Selloff Finally Over?

GE HealthCare Technologies Inc. (NASDAQ:GEHC) specializes in hospital imaging, including MRI, CT, and ultrasound machines, and the contrast agents required to interpret scans.

Keep Reading →

September 23 - Hedge Funds, News

Equity LifeStyle (ELS) Slides Near 52-Week Lows: Can Core Rental Stability Offset Higher Rates?

Equity LifeStyle Properties, Inc. (NYSE:ELS) operates manufactured-home communities, recreational vehicle (RV) resorts, and marinas.

Keep Reading →

September 22 - Hedge Funds, News

Constellation (STZ) Brands Hit a 52-Week Low. Is the Corona-and-Modelo Machine Broken, or On Sale?

Constellation Brands, Inc. (NYSE:STZ) owns the rights to some of the biggest names in imported beer in the US, including Corona, Modelo Especial, and Pacífico.

Keep Reading →

September 22 - Hedge Funds, News

Flutter (FLUT), The World’s Biggest Betting Company Has Lost Two-Thirds of Its Value. Is the Bottom In?

Flutter Entertainment plc (NYSE:FLUT) owns one of the most popular sportsbooks in America, FanDuel.

Keep Reading →

September 22 - Hedge Funds, News

A Failed Auction and a 15% Drop: Is Cooper Companies (COO) a Value Trap or a Bargain?

For almost nine months, The Cooper Companies, Inc. (NASDAQ:COO) has been trying to sell its CooperSurgical unit.

Keep Reading →

September 20 - Hedge Funds, News

Lennox is Down 38% and Trading at 52-Week Lows. Bargain or Value Trap?

Deutsche Bank downgraded Lennox International Inc. (NYSE:LII) to Hold on September 14, 2026, but left the price target at $444.

Keep Reading →

September 20 - Hedge Funds, News

Huntington Cut Its Outlook Right as the Fed Hiked. First Crack in Regional-Bank Margins?

Huntington Bancshares Incorporated (NASDAQ:HBAN) dropped 5.55% to $15.82 on September 16, 2026, close to its 52-week low.

Keep Reading →

September 20 - Hedge Funds, News

The Semaglutide Cliff vs. a 10x Multiple: Is Novo Nordisk (NVO) a Value Trap or a Bargain?

Morgan Stanley has cut Novo Nordisk A/S (NYSE:NVO) to Underweight on September 11, 2026.

Keep Reading →

September 20 - Hedge Funds, News

Is Chewy’s (CHWY) Margin Story Losing Steam, or Is a 48% Drop the Opportunity?

Chewy, Inc. (NYSE:CHWY) reported second-quarter results on September 9, 2026.

Keep Reading →

September 13 - News

Boston Scientific (BSX) Didn’t Miss on Demand or Devices. A Cyberattack Just Broke Its Guidance.

Boston Scientific Corporation (NYSE:BSX) fell 2.3% in early trading on September 8, 2026, after disclosing that an August 25 cyberattack disrupted manufacturing and shipping.

Keep Reading →

September 13 - Hedge Funds, News

« Older Entries

Get our editor’s daily picks straight in your inbox!

RSS Feed Hedge Funds Insider Trading About Us Authors Contact Us Sitemap
Privacy Policy Terms of Use Disclosure Policy FAQ CCPA - Do Not Sell My Information. ©2026 Koala Guide LLC.